Schonfeld Strategic Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.52M	Buy	+48,765	New	+$2.48M	0.02%	729
2025 Q2	–	Sell	-46,830	Closed	-$1.53M	–	2523
2025 Q1	$1.53M	Buy	46,830 +36,100	+336%	+$1.28M	0.01%	1084
2024 Q4	$388K	Buy	+10,730	New	+$378K	﹤0.01%	1507
2024 Q1	–	Sell	-32,219	Closed	-$932K	–	2396
2023 Q4	$932K	Sell	32,219 -4,939	-13%	-$131K	0.01%	1061
2023 Q3	$1.02M	Sell	37,158 -61,730	-62%	-$1.88M	0.01%	1017
2023 Q2	$2.97M	Sell	98,888 -24,745	-20%	-$866K	0.03%	636
2023 Q1	$4.48M	Buy	123,633 +57,728	+88%	+$2.22M	0.04%	471
2022 Q4	$2.35M	Buy	65,905 +49,105	+292%	+$1.71M	0.02%	761
2022 Q3	$569K	Buy	+16,800	New	+$547K	﹤0.01%	1660
2022 Q2	–	Sell	-79,801	Closed	-$2.58M	–	2981
2022 Q1	$2.58M	Buy	79,801 +67,501	+549%	+$2.07M	0.02%	649
2021 Q4	$359K	Buy	+12,300	New	+$373K	﹤0.01%	1435
2017 Q4	–	Sell	-19,967	Closed	-$799K	–	874
2017 Q3	$799K	Buy	+19,967	New	+$864K	0.07%	302